Whisk Products Inc – FDA 483, Jun 26, 2026

Whisk Products Inc, an OTC drug manufacturer in Wentzville, MO, received a Form FDA 483 with five observations highlighting significant deficiencies in their quality system. Issues included inadequate raw material testing, deficient quality control procedures, failure to investigate out-of-specification results, improper equipment cleaning, and an insufficient stability program, indicating a broad lack of adherence to current good manufacturing practices.